381. Effect of Ceftriaxone+sulbactam+disodium EDTA Combination in Treatment of Complicated Urinary Tract Infections Caused by Metallo Beta-lactamase Producing Enterobacterales: An Open Label Randomized Controlled Trial

BACKGROUND: Ceftriaxone+sulbactam+disodium EDTA (CSE) is a novel antibiotic-adjuvant combination, approved by Drug Controller General of India (DCGI) against Extended Spectrum Beta-lactamase (ESBL) producing Gram-negative bacilli. Though randomized controlled trials (RCTs) have been conducted to pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Samantaray, Subhashree, Kumar, Deepak, Bohra, Gopal Krishana, Meena, Durga Shankar, Agarwal, Ashwini, Chaudhary, Gautam Ram, Tak, Vibhor, Sharma, Ankur, Garg, M K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677394/
http://dx.doi.org/10.1093/ofid/ofad500.451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677394/
http://dx.doi.org/10.1093/ofid/ofad500.451

Ejemplares similares